Literature DB >> 11034388

CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation.

F Michel1, G Mangino, G Attal-Bonnefoy, L Tuosto, A Alcover, A Roumier, D Olive, O Acuto.   

Abstract

The mechanism through which CD28 costimulation potentiates TCR-driven gene expression is still not clearly defined. Vav-1, an exchange factor for Rho GTPases thought to regulate, mainly through Rac-1, various signaling components leading to cytokine gene expression, is tyrosine phosphorylated upon CD28 engagement. Here, we provide evidence for a key role of Vav-1 in CD28-mediated signaling. Overexpression of Vav-1 in Jurkat cells in combination with CD28 ligation strongly reduced the concentration of staphylococcus enterotoxin E/MHC required for TCR-induced NF-AT activation. Surprisingly, upon Vav-1 overexpression CD28 ligation sufficed to activate NF-AT in the absence of TCR engagement. This effect was not mediated by overexpression of ZAP-70 nor of SLP-76 but necessitated the intracellular tail of CD28, the intactness of the TCR-proximal signaling cascade, the Src-homology domain 2 (SH2) domain of Vav-1, and SLP-76 phosphorylation, an event which was favored by Vav-1 itself. Cells overexpressing Vav-1 formed lamellipodia and microspikes reminiscent of Rac-1 and Cdc42 activation, respectively, for which the SH2 domain of Vav-1 was dispensable. Together, these data suggest that CD28 engagement activates Vav-1 to boost TCR signals through a synergistic cooperation between Vav-1 and SLP-76 and probably via cortical actin changes to facilitate the organization of a signaling zone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034388     DOI: 10.4049/jimmunol.165.7.3820

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  EMBO WORKSHOP REPORT: lymphocyte antigen receptor and coreceptor signaling Siena, Italy, November 6-10, 1999.

Authors:  C T Baldari; J L Telford; O Acuto
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

Review 2.  Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?

Authors:  Zili Zhang; James T Rosenbaum; Wenwei Zhong; Carmen Lim; David J Hinrichs
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

Review 3.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

Review 4.  From tango to quadrilla: current views of the immunological synapse.

Authors:  Cristina Mazzon; Antonella Viola
Journal:  Cell Adh Migr       Date:  2007-01-07       Impact factor: 3.405

5.  CD28 co-signaling in the adaptive immune response.

Authors:  Pavel Riha; Christopher E Rudd
Journal:  Self Nonself       Date:  2010-07-12

6.  CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters.

Authors:  Barbara Marinari; Antonio Costanzo; Valeria Marzano; Enza Piccolella; Loretta Tuosto
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

7.  CD28 and Grb-2, relative to Gads or Grap, preferentially co-operate with Vav1 in the activation of NFAT/AP-1 transcription.

Authors:  Helga Schneider; Christopher E Rudd
Journal:  Biochem Biophys Res Commun       Date:  2008-02-22       Impact factor: 3.575

8.  Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.

Authors:  Sarah R Jacobs; Catherine E Herman; Nancie J Maciver; Jessica A Wofford; Heather L Wieman; Jeremy J Hammen; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 9.  Regulation of immune responses by E3 ubiquitin ligase Cbl-b.

Authors:  Rong Tang; Wallace Y Langdon; Jian Zhang
Journal:  Cell Immunol       Date:  2018-11-07       Impact factor: 4.868

10.  T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b.

Authors:  Guilin Qiao; Zhenping Li; Luciana Molinero; Maria-Luisa Alegre; Haiyan Ying; Zuoming Sun; Josef M Penninger; Jian Zhang
Journal:  Mol Cell Biol       Date:  2008-01-28       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.